{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T11:20:01Z","timestamp":1774437601300,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","europeanneuropsychopharmacology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.euroneuro.2017.06.002","type":"journal-article","created":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T22:30:25Z","timestamp":1498170625000},"page":"828-832","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Epigenetic induction of melatonin MT 1 receptors by valproate: Neurotherapeutic implications"],"prefix":"10.1016","volume":"27","author":[{"given":"Sarra G.","family":"Bahna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lennard P.","family":"Niles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2017.06.002_bib1","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.neulet.2014.05.056","article-title":"Regional upregulation of hippocampal melatonin MT2 receptors by valproic acid: therapeutic implications for Alzheimer\u05f3s disease","volume":"576","author":"Bahna","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.euroneuro.2017.06.002_bib2","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/cr.2011.22","article-title":"Regulation of chromatin by histone modifications","volume":"21","author":"Bannister","year":"2011","journal-title":"Cell Res."},{"key":"10.1016\/j.euroneuro.2017.06.002_bib3","first-page":"892","article-title":"Regulation of the Mel 1a melatonin receptor mRNA and protein levels in the ovine pars tuberalis: evidence for a cyclic adenosine 3\u2032,5\u2032-monophosphate-independent Mel 1a receptor coupling and an autoregulatory mechanism of expression","volume":"10","author":"Barrett","year":"1996","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.euroneuro.2017.06.002_bib4","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1039\/b703830p","article-title":"Isoform-selective histone deacetylase inhibitors","volume":"37","author":"Bieliauskas","year":"2008","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.euroneuro.2017.06.002_bib5","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/j.1471-4159.2005.03457.x","article-title":"Novel targets for valproic acid: up-regulation of melatonin receptors and neurotrophic factors in C6 glioma cells","volume":"95","author":"Castro","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.euroneuro.2017.06.002_bib6","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrg2540","article-title":"Linking DNA methylation and histone modification: patterns and paradigms","volume":"10","author":"Cedar","year":"2009","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.euroneuro.2017.06.002_bib7","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.freeradbiomed.2012.01.030","article-title":"Melatonin ameliorates neural function by promoting endogenous neurogenesis through the MT2 melatonin receptor in ischemic-stroke mice","volume":"52","author":"Chern","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.euroneuro.2017.06.002_bib8","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.biocel.2016.03.012","article-title":"Epigenetic regulation of G protein coupled receptor signaling and its implications in psychiatric disorders","volume":"77","author":"Dogra","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.euroneuro.2017.06.002_bib9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejphar.2007.01.022","article-title":"Human melatonin MT1 receptor induction by valproic acid and its effects in combination with melatonin on MCF-7 breast cancer cell proliferation","volume":"560","author":"Jawed","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2017.06.002_bib10","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejphar.2008.04.058","article-title":"Clinically relevant concentrations of valproic acid modulate melatonin MT(1) receptor, HDAC and MeCP2 mRNA expression in C6 glioma cells","volume":"589","author":"Kim","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2017.06.002_bib11","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/jpi.12224","article-title":"Anatomical and cellular localization of melatonin MT and MT receptors in the adult rat brain","volume":"58","author":"Lacoste","year":"2015","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.euroneuro.2017.06.002_bib12","doi-asserted-by":"crossref","first-page":"14575","DOI":"10.3390\/ijms140714575","article-title":"Melatonin in Alzheimer\u05f3s disease","volume":"14","author":"Lin","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.euroneuro.2017.06.002_bib13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1146\/annurev-pharmtox-010814-124742","article-title":"MT1 and MT2 melatonin receptors: a therapeutic perspective","volume":"56","author":"Liu","year":"2015","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.euroneuro.2017.06.002_bib14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/bcpt.12079","article-title":"Melatonin attenuates isoflurane-induced acute memory impairments in aged rats","volume":"113","author":"Liu","year":"2013","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.euroneuro.2017.06.002_bib15","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature04020","article-title":"LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription","volume":"437","author":"Metzger","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.euroneuro.2017.06.002_bib16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2174\/1874467210902010095","article-title":"Biochemical, molecular and epigenetic mechanisms of valproic acid neuroprotection","volume":"2","author":"Monti","year":"2009","journal-title":"Curr. Mol. Pharmacol."},{"key":"10.1016\/j.euroneuro.2017.06.002_bib17","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1017\/S1461145711001969","article-title":"Valproic acid up-regulates melatonin MT1 and MT2 receptors and neurotrophic factors CDNF and MANF in the rat brain","volume":"15","author":"Niles","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2017.06.002_bib18","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1182\/blood-2006-12-060947","article-title":"Inhibition of glycogen synthase kinase-3 activity leads to epigenetic silencing of nuclear factor kappaB target genes and induction of apoptosis in chronic lymphocytic leukemia B cells","volume":"110","author":"Ougolkov","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.euroneuro.2017.06.002_bib19","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1093\/nar\/30.9.e36","article-title":"Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR","volume":"30","author":"Pfaffl","year":"2002","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.euroneuro.2017.06.002_bib20","doi-asserted-by":"crossref","first-page":"36734","DOI":"10.1074\/jbc.M101287200","article-title":"Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen","volume":"276","author":"Phiel","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.euroneuro.2017.06.002_bib21","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nature09817","article-title":"Increasing adult hippocampal neurogenesis is sufficient to improve pattern separation","volume":"472","author":"Sahay","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.euroneuro.2017.06.002_bib22","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1017\/S1461145708009024","article-title":"Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons","volume":"11","author":"Wu","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2017.06.002_bib23","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jad.2012.12.025","article-title":"Alterations of melatonin receptors MT1 and MT2 in the hypothalamic suprachiasmatic nucleus during depression","volume":"148","author":"Wu","year":"2013","journal-title":"J. Affect. Disord."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X17302791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X17302791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T13:51:34Z","timestamp":1535723494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X17302791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0924977X17302791"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2017.06.002","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epigenetic induction of melatonin MT1 receptors by valproate: Neurotherapeutic implications","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2017.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}